Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.
作者信息
Hemming V G
机构信息
Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA.
出版信息
Clin Diagn Lab Immunol. 2001 Sep;8(5):859-63. doi: 10.1128/CDLI.8.5.859-863.2001.
Abstract
摘要
相似文献
1
Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.静脉注射免疫球蛋白在传染病预防或治疗中的应用。
Clin Diagn Lab Immunol. 2001 Sep;8(5):859-63. doi: 10.1128/CDLI.8.5.859-863.2001.
2
Role of passive immunotherapies in managing infectious outbreaks.被动免疫疗法在控制传染病爆发中的作用。
Biologicals. 2012 May;40(3):196-9. doi: 10.1016/j.biologicals.2012.01.001. Epub 2012 Feb 21.
3
[Indications for passive immunotherapy in infectious diseases].[传染病被动免疫疗法的适应症]
Schweiz Med Wochenschr. 1987 Jan 17;117(3):84-90.
4
Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases.多克隆免疫球蛋白和高免疫球蛋白在传染病的预防和治疗中的应用。
Infect Dis Clin North Am. 2011 Dec;25(4):773-88. doi: 10.1016/j.idc.2011.07.005.
5
[The use of immunoglobulins in the treatment of infectious diseases].[免疫球蛋白在传染病治疗中的应用]
Pol Merkur Lekarski. 2011 Jun;30(180):441-7.
6
Vaccination against infectious diseases: what is promising?传染病疫苗接种：有哪些有前景的疫苗？
Med Microbiol Immunol. 2014 Dec;203(6):365-71. doi: 10.1007/s00430-014-0346-1. Epub 2014 Jul 27.
7
Passive immunotherapy of sepsis with intravenous immune globulin: not all IVIg preparations are created equal.静脉注射免疫球蛋白用于脓毒症的被动免疫疗法：并非所有静脉注射免疫球蛋白制剂都是一样的。
Crit Care. 2012 Jan 25;16(1):407. doi: 10.1186/cc10607.
8
[Immunotherapy: the strategic approach to the treatment of patients with severe sepsis].
Klin Khir. 2005 Jul(7):32-7.
9
[Immunoglobulins and rules of passive-active prophylaxis].[免疫球蛋白与被动-主动预防规则]
Przegl Epidemiol. 2003;57(2):391-7.
10
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.静脉注射免疫球蛋白在人类疾病中的应用：美国过敏、哮喘与免疫学会原发性免疫缺陷委员会成员的证据综述
J Allergy Clin Immunol. 2006 Apr;117(4 Suppl):S525-53. doi: 10.1016/j.jaci.2006.01.015.
引用本文的文献
1
Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review.利妥昔单抗联合静脉注射免疫球蛋白治疗自身免疫性疾病：一项系统评价
Adv Rheumatol. 2025 Mar 25;65(1):19. doi: 10.1186/s42358-025-00450-x.
2
Simultaneous Isolation and Purification of Transferrin and Immunoglobulin G from Human Serum-A New Biotech Solution.从人血清中同时分离纯化转铁蛋白和免疫球蛋白G——一种新的生物技术解决方案
Molecules. 2025 Feb 21;30(5):993. doi: 10.3390/molecules30050993.
3
Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study.辅助静脉注射免疫球蛋白对术后继发性腹膜炎重症患者的影响：一项回顾性研究
Acute Crit Care. 2023 Feb;38(1):21-30. doi: 10.4266/acc.2022.01515. Epub 2023 Feb 27.
4
Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.新型静脉用免疫球蛋白治疗用于预防和治疗耳念珠菌和白念珠菌播散性念珠菌病。
mSphere. 2023 Feb 21;8(1):e0058422. doi: 10.1128/msphere.00584-22. Epub 2023 Jan 23.
5
Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.转染色体牛来源的广谱中和抗体作为强大的生物治疗药物，可有效应对重要新兴病毒病原体，特别关注 SARS-CoV-2、MERS-CoV、埃博拉病毒、寨卡病毒、HIV-1 和甲型流感病毒。
J Med Virol. 2022 Oct;94(10):4599-4610. doi: 10.1002/jmv.27907. Epub 2022 Jun 11.
6
In vitro and in vivo methods to study bacterial colonization of hydrogel dermal fillers.研究水凝胶真皮填充剂细菌定植的体外和体内方法。
J Biomed Mater Res B Appl Biomater. 2022 Aug;110(8):1932-1941. doi: 10.1002/jbm.b.35050. Epub 2022 Mar 30.
7
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.随机对照试验：输注恢复期血浆作为暴露后预防新型冠状病毒2感染的措施
medRxiv. 2021 Dec 14:2021.12.13.21267611. doi: 10.1101/2021.12.13.21267611.
8
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease.静脉注射用 Zika 病毒免疫球蛋白预防或加重 Zika 病毒病的能力。
Front Immunol. 2021 Sep 6;12:717425. doi: 10.3389/fimmu.2021.717425. eCollection 2021.
9
Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective.静脉注射免疫球蛋白（IVIG）在调控危重症 COVID-19 炎症中的应用：理论视角。
Med Hypotheses. 2021 Jun;151:110592. doi: 10.1016/j.mehy.2021.110592. Epub 2021 Apr 9.
10
Immunogenic properties of immunoglobulin superfamily members within complex biological networks.免疫球蛋白超家族成员在复杂生物网络中的免疫原性特性。
Cell Immunol. 2020 Dec;358:104235. doi: 10.1016/j.cellimm.2020.104235. Epub 2020 Oct 11.
本文引用的文献
1
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION AND ATTENUATION OF MEASLES.人血浆分馏产物的化学、临床及免疫学研究。十二、浓缩正常人血清丙种球蛋白（人免疫血清球蛋白）在预防和减轻麻疹中的应用。
J Clin Invest. 1944 Jul;23(4):541-9. doi: 10.1172/JCI101519.
2
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES.人血浆成分制品的化学、临床及免疫学研究。十一、浓缩正常人血清γ球蛋白（人免疫血清球蛋白）在麻疹预防和治疗中的应用
J Clin Invest. 1944 Jul;23(4):531-40. doi: 10.1172/JCI101518.
3
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA.人血浆成分制品的化学、临床及免疫学研究。I. 人血浆蛋白组分的特性
J Clin Invest. 1944 Jul;23(4):417-32. doi: 10.1172/JCI101508.
4
5
Serum gamma globulin levels in normal infants.正常婴儿的血清γ球蛋白水平。
Pediatrics. 1955 Nov;16(5):575-84.
6
Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group.帕利珠单抗的有效性：对1998至1999年呼吸道合胞病毒流行季结局的评估。帕利珠单抗结局研究组
Pediatr Infect Dis J. 2000 Nov;19(11):1068-71. doi: 10.1097/00006454-200011000-00007.
7
Antibodies and resistance to natural HIV infection.抗体与对自然HIV感染的抵抗力。
N Engl J Med. 2000 Oct 26;343(17):1263-5. doi: 10.1056/NEJM200010263431711.
8
Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G.免疫球蛋白G水平低的早产儿发生新生儿败血症的风险增加，但预防性使用免疫球蛋白G并无益处。
J Pediatr. 2000 Nov;137(5):623-8. doi: 10.1067/mpd.2000.109791.
9
Additional confirmation of the lack of effect of intravenous immunoglobulin in the prevention of neonatal infection.静脉注射免疫球蛋白在预防新生儿感染方面缺乏效果的进一步证实。
J Pediatr. 2000 Nov;137(5):595-7. doi: 10.1067/mpd.2000.110982.
10
Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.静脉注射免疫球蛋白预防早产和/或低出生体重婴儿感染
Cochrane Database Syst Rev. 2000(2):CD000361. doi: 10.1002/14651858.CD000361.
Zotero 插件